FindTrial
Sign In

Prospective , one center, case-control study about efficacy of IP-10 and MCP-2 for the diagnosis of tuberculosis

Efficacy of IP-10 and MCP-2 for the diagnosis of tuberculosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000061
Enrollment
200
Registered
2010-12-01
Start date
2010-11-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. age > 20 2. Diagnosed with tuberculosis

Exclusion criteria

Exclusion criteria: Tuberculosis patients 1.immunosuppressed condition including HIV infection, anti-chemotherpy, hematologic malignancy, transplantation and autoimmune disease 2. The patient who dosen't agree with participating the trials 3. The patient who is hypersensitive to PPD and TST test

Design outcomes

Primary

MeasureTime frame
IP-2 ;MCP-2—

Secondary

MeasureTime frame
interferon- gamma—

Countries

Korea, Republic of

Contacts

Public ContactJi young Hong

Yonsei University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026